NCI clinical trials will cover areas neglected by industry

NCI will focus its clinical research on topics that are neglected by industry, including low-prevalence cancers and the de-escalation of therapeutic intensity, NCI Director Norman (Ned) Sharpless said in remarks Friday and in a Viewpoint published Thursday

Read the full 370 word article

User Sign In